论文部分内容阅读
目的:分析依达拉奉注射液与银杏达莫注射液在出血性脑梗死治疗中的临床效果。方法:选取2013年1月-2014年7月收治的出血性脑梗死患者120例,将其随机分为对照组与观察组,对照组患者使用丹参注射液进行治疗,观察组患者使用依达拉奉注射液与银杏达莫进行治疗,观察两组患者的临床治疗效果,并进行分析对比。结果:观察组患者治疗后神经功能缺损程度评分与对照组患者比较,差异具有统计学意义(P<0.05);观察组患者的总显效率为68.33%、治疗总有效率为86.66%,与对照组的36.66%、58.33%比较,差异具有统计学意义(P<0.05)。结论:依达拉奉注射液与银杏达莫注射液在出血性脑梗死患者的治疗中效果明显。
Objective: To analyze the clinical effect of edaravone injection and gingko-damo injection in the treatment of hemorrhagic cerebral infarction. Methods: A total of 120 patients with hemorrhagic cerebral infarction who were admitted to our hospital from January 2013 to July 2014 were randomly divided into control group and observation group. Patients in control group were treated with Salvia miltiorrhiza injection. Patients in observation group were treated with edaravone Bong injection and gingko Damo treatment, the clinical efficacy of two groups of patients were observed and compared. Results: The score of neurological deficit in observation group was significantly higher than that in control group (P <0.05). The total effective rate in observation group was 68.33% and the total effective rate was 86.66% 36.66%, 58.33% of the group, the difference was statistically significant (P <0.05). Conclusion: Edaravone and Ginkgo biloba injection are effective in the treatment of patients with hemorrhagic cerebral infarction.